Does ENZALUTAMIDE Cause Dysgeusia? 547 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 547 reports of Dysgeusia have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.1% of all adverse event reports for ENZALUTAMIDE.
547
Reports of Dysgeusia with ENZALUTAMIDE
1.1%
of all ENZALUTAMIDE reports
46
Deaths
70
Hospitalizations
How Dangerous Is Dysgeusia From ENZALUTAMIDE?
Of the 547 reports, 46 (8.4%) resulted in death, 70 (12.8%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Dysgeusia Listed in the Official Label?
Yes, Dysgeusia is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Dysgeusia?
NIRMATRELVIR\RITONAVIR (7,381)
SUNITINIB MALATE (1,226)
SODIUM (1,216)
LENALIDOMIDE (1,180)
LIFITEGRAST (1,067)
CABOZANTINIB S-MALATE (777)
CLARITHROMYCIN (717)
VISMODEGIB (706)
ADALIMUMAB (674)
PALBOCICLIB (620)
Which ENZALUTAMIDE Alternatives Have Lower Dysgeusia Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE